Dr. Yuhei Kobayashi, MD

Dr. Kobayashi practices at Kings Physician Services in Yorktown Heights, New York.

Dr. Kobayashi's NPI, 1134608508, was assigned on August 7, 2018. Dr. Kobayashi graduated from Osaka University Medical School in 2008. Dr. Kobayashi holds New York license 302924.

Dr. Kobayashi's primary practice is Kings Physician Services, at 2649 Strang Blvd, Yorktown Heights, NY 10598 in Westchester County. The practice phone is (718) 780-5051.

Dr. Kobayashi's primary practice is Kings Physician Services in Yorktown Heights, New York. Dr. Kobayashi is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Kobayashi to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kobayashi practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Kobayashi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Kobayashi's licenses on file in 2 states: New York and California.

Dmand AI lists angioplasty, cardiac catheterization, circulation problems and pacemaker replacement among the conditions Dr. Kobayashi treats.

CMS data shows 326 Medicare services from Dr. Kobayashi across 10 procedure codes in 2024, for 157 Medicare patients. Medicare paid $43,491 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 157 Medicare patients who saw Dr. Kobayashi in 2024. The largest group is 75 to 84, with 65 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 50% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kobayashi's median patient age at 72, with 44% women.

In 2024, Dr. Kobayashi wrote 283 Medicare Part D claims for 75 patients. 84% of them were for generic drugs. CMS names the drug for 170 of them, across 7 drugs with 11 or more claims each, at $12,539 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Kobayashi for performance year 2024, reported as part of a group. Dr. Kobayashi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of coronary angioplasty and stenting by Dr. Kobayashi, more than 63% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 115 papers to Dr. Kobayashi, published from 2011 to 2025. 2016 was the busiest year, with 10. The most frequent topics are Coronary Artery Disease, Coronary Angiography and Coronary Vessels. Dr. Kobayashi has published most often in JACC Cardiovasc Interv. Dr. Kobayashi's most frequent co-authors are William Fuller Fearon, MD, Alan Ching-Yuen Yeung, MD and Tatsunori Takahashi, MD.

Dmand AI links Dr. Kobayashi to 1 clinical trial. Conditions studied include Coronary Stenosis and Coronary Artery Disease.

CMS Open Payments shows 100 general payments to Dr. Kobayashi from 16 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 80% of the total. Abbott Laboratories paid the most, $18,186.

Dr. Kobayashi graduated from Osaka University Medical School in 2008.

Dr. Kobayashi is in network with 15 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.